Unknown

Dataset Information

0

A Class of FeIII Macrocyclic Complexes with Alcohol Donor Groups as Effective T1 MRI Contrast Agents.

ABSTRACT: Early studies suggested that FeIII complexes cannot compete with GdIII complexes as T1 MRI contrast agents. Now it is shown that one member of a class of high-spin macrocyclic FeIII complexes produces more intense contrast in mice kidneys and liver at 30?minutes post-injection than does a commercially used GdIII agent and also produces similar T1 relaxivity in serum phantoms at 4.7?T and 37?°C. Comparison of four different FeIII macrocyclic complexes elucidates the factors that contribute to relaxivity in?vivo including solution speciation. Variable-temperature 17 O NMR studies suggest that none of the complexes has a single, integral inner-sphere water that exchanges rapidly on the NMR timescale. MRI studies in mice show large in?vivo differences of three of the FeIII complexes that correspond, in part, to their r1 relaxivity in phantoms. Changes in overall charge of the complex modulate contrast enhancement, especially of the kidneys.

SUBMITTER: Snyder EM 

PROVIDER: S-EPMC7502272 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A Class of Fe<sup>III</sup> Macrocyclic Complexes with Alcohol Donor Groups as Effective T<sub>1</sub> MRI Contrast Agents.

Snyder Eric M EM   Asik Didar D   Abozeid Samira M SM   Abozeid Samira M SM   Burgio Ariel A   Bateman Gage G   Turowski Steven G SG   Spernyak Joseph A JA   Morrow Janet R JR  

Angewandte Chemie (International ed. in English) 20191220 6

Early studies suggested that Fe<sup>III</sup> complexes cannot compete with Gd<sup>III</sup> complexes as T<sub>1</sub> MRI contrast agents. Now it is shown that one member of a class of high-spin macrocyclic Fe<sup>III</sup> complexes produces more intense contrast in mice kidneys and liver at 30 minutes post-injection than does a commercially used Gd<sup>III</sup> agent and also produces similar T<sub>1</sub> relaxivity in serum phantoms at 4.7 T and 37 °C. Comparison of four different Fe<sup>  ...[more]

Similar Datasets

Unknown Modulating the Properties of Fe(III) Macrocyclic MRI Contrast Agents by Appending Sulfonate or Hydroxyl Groups.
| S-EPMC7288058 | biostudies-literature
Unknown Defining the conditions for the development of the emerging class of Fe<sup>III</sup>-based MRI contrast agents.
| S-EPMC8386674 | biostudies-literature
Unknown Fe(III)-templated Gd(III) self-assemblies-a new route toward macromolecular MRI contrast agents.
| S-EPMC3190973 | biostudies-literature
Unknown Fe-HBED Analogs: A Promising Class of Iron-Chelate Contrast Agents for Magnetic Resonance Imaging.
| S-EPMC6961518 | biostudies-literature
Unknown Polycatechol Nanoparticle MRI Contrast Agents.
| S-EPMC5441847 | biostudies-literature
Unknown Gadolinium-based Contrast Agents for Cardiac MRI: Use of Linear and Macrocyclic Agents with Associated Safety Profile from 154 779 European Patients.
| S-EPMC7977928 | biostudies-literature
Unknown Iron(II) PARACEST MRI contrast agents.
| S-EPMC3170541 | biostudies-literature
Unknown Impact of Serum Proteins on MRI Contrast Agents: Cellular Binding and T<sub>2</sub> relaxation.
| S-EPMC4255963 | biostudies-literature
Unknown Macromolecules with Different Charges, Lengths, and Coordination Groups for the Coprecipitation Synthesis of Magnetic Iron Oxide Nanoparticles as <i>T</i><sub>1</sub> MRI Contrast Agents.
| S-EPMC6567071 | biostudies-literature
Unknown Liposomal Fe(III) Macrocyclic Complexes with Hydroxypropyl Pendants as MRI Probes.
| S-EPMC9124523 | biostudies-literature